Antibody-Drug Conjugates and Targeted Treatment Strategies for Hepatocellular Carcinoma: A Drug-Delivery Perspective

by David Dahlgren, Hans Lennernäs
Published 2020-06-01

Intestinal Permeability and Drug Absorption: Predictive Experimental, Computational and In Vivo Approaches

by David Dahlgren, Hans Lennernäs
Published 2019-08-01

Intestinal absorption of BCS class II drugs administered as nanoparticles: A review based on in vivo data from intestinal perfusion models

by David Dahlgren, Erik Sjögren, Hans Lennernäs
Published 2020-09-01

The In Vivo Effect of Transcellular Permeation Enhancers on the Intestinal Permeability of Two Peptide Drugs Enalaprilat and Hexarelin

by David Dahlgren, Markus Sjöblom, Mikael Hedeland, Hans Lennernäs
Published 2020-01-01

Chemotherapeutics-Induced Intestinal Mucositis: Pathophysiology and Potential Treatment Strategies

by David Dahlgren, Markus Sjöblom, Per M Hellström, Hans Lennernäs
Published 2021-05-01

Effect of paracellular permeation enhancers on intestinal permeability of two peptide drugs, enalaprilat and hexarelin, in rats

by David Dahlgren, Tobias Olander, Markus Sjöblom, Mikael Hedeland, Hans Lennernäs
Published 2021-06-01

Liver Cancer Cell Lines Treated with Doxorubicin under Normoxia and Hypoxia: Cell Viability and Oncologic Protein Profile

by Ilse R. Dubbelboer, Natasa Pavlovic, Femke Heindryckx, Erik Sjögren, Hans Lennernäs
Published 2019-07-01

Model-Informed Drug Discovery and Development Strategy for the Rapid Development of Anti-Tuberculosis Drug Combinations

by Rob C. van Wijk, Rami Ayoun Alsoud, Hans Lennernäs, Ulrika S. H. Simonsson
Published 2020-03-01

Simultaneous assessment of lipid classes and bile acids in human intestinal fluid by solid-phase extraction and HPLC methods

by Eva Persson, Lars Löfgren, Göran Hansson, Bertil Abrahamsson, Hans Lennernäs, Ralf Nilsson
Published 2007-01-01

Leveraging Oral Drug Development to a Next Level: Impact of the IMI-Funded OrBiTo Project on Patient Healthcare

by Bart Hens, Bart Hens, Patrick Augustijns, Hans Lennernäs, Mark McAllister, Bertil Abrahamsson
Published 2021-03-01

Regional Intestinal Drug Permeability and Effects of Permeation Enhancers in Rat

by David Dahlgren, Maria-Jose Cano-Cebrián, Tobias Olander, Mikael Hedeland, Markus Sjöblom, Hans Lennernäs
Published 2020-03-01

Anthracyclins Increase PUFAs: Potential Implications in ER Stress and Cell Death

by David Balgoma, Fredrik Kullenberg, Carlemi Calitz, Maria Kopsida, Femke Heindryckx, Hans Lennernäs, Mikael Hedeland
Published 2021-05-01

Prevention of Rat Intestinal Injury with a Drug Combination of Melatonin and Misoprostol

by David Dahlgren, Maria-José Cano-Cebrián, Per M. Hellström, Alkwin Wanders, Markus Sjöblom, Hans Lennernäs
Published 2020-09-01

Effects of a novel combination of orlistat and acarbose on tolerability, appetite, and glucose metabolism in persons with obesity

by Ulf Holmbäck, Anders Forslund, Stefan Grudén, Göran Alderborn, Arvid Söderhäll, Per M. Hellström, Hans Lennernäs
Published 2020-06-01

In Vitro Cell Toxicity and Intracellular Uptake of Doxorubicin Exposed as a Solution or Liposomes: Implications for Treatment of Hepatocellular Carcinoma

by Fredrik Kullenberg, Oliver Degerstedt, Carlemi Calitz, Nataša Pavlović, David Balgoma, Johan Gråsjö, Erik Sjögren, Mikael Hedeland, Femke Heindryckx, Hans Lennernäs
Published 2021-07-01